Concepedia

Publication | Closed Access

2.23 Covalent Inhibition of Btk with Clinical Development Compound AVL-292 Disrupts Signaling That Maintains the Microenvironment Necessary for Chronic Lymphocytic Leukemia Growth

12

Citations

0

References

2011

Year

No additional data available for this publication yet. Check back later!